Panacea Biotec awarded the manufacturing license to produce Sputnik V


Panacea Biotec awarded the manufacturing license to produce Sputnik V: Pharmaceutical firm Panacea Biotec said that it has received manufacturing license from Drugs Controller General of India (DCGI) for Sputnik V vaccine against Covid-19 pursuant to its collaboration with Russian Direct Investment Fund (Russia’s sovereign wealth fund).

Comments

Popular posts from this blog

Eurotech has carved its niche to address Networking and Communications requirements.

CLOUD COMPUTING : Nitin Hiranandani, Director, HP India

DCIM gaining momentum with growth of data centers